MARKET

INRX

INRX

Intrinsic Medicine, Inc
NASDAQ
--
0.00
0.00%
Opening
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
No Data
About INRX
Intrinsic Medicine Inc is a United States-based preclinical-stage therapeutics company. The Company's initial drug candidates are based on bioactive oligosaccharides naturally produced in human milk, or Human Milk Oligosaccharides (HMOs) which directly modulate the immune system and other human cells as well as the gut microbiome. The Company's Oligosaccharide Medicines (OMs) are synthetic biology-produced drugs equivalent to HMOs. The Company's pipeline consists of human-identical milk oligosaccharide (HiMO) drug candidates, including OM001 (HiMO 3’sialyllactose), OM002 (HiMO 2’-fucosyllactose), and OM003 (HiMO 6’-sialyllactose). Its pipeline has the potential to treat gut-brain axis disorders (GBA), and certain inflammatory disorders. Its HiMO drug candidates is suitable for convenient oral administration. HiMO drug candidates enable a diverse pipeline of addressable diseases, both within a single HiMO drug candidate and across multiple HiMO drug candidates.

Webull offers Intrinsic Medicine Inc stock information, including NASDAQ: INRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INRX stock methods without spending real money on the virtual paper trading platform.